Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease

The Alzheimer's disease (AD) epidemic is a looming crisis, with an urgent need for new therapies to delay or prevent symptom onset and progression. There is growing awareness that clinical trials must target stage-appropriate pathophysiological mechanisms to effectively develop disease-modifyin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chalermpalanupap, Termpanit, Kinkead, Becky, Hu, William T, Kummer, Markus P, Hammerschmidt, Thea, Heneka, Michael T, Weinshenker, David, Levey, Allan I
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3706916/
https://ncbi.nlm.nih.gov/pubmed/23634965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt175
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars